Stock listing
Intron Biotechnology, Inc.
Selected listing: 048530 · KRX · KRW · KR
Intron Biotechnology, Inc. (KRX:048530), Health Technology. Latest release Aug 26, 2025: iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based…
- Ticker
- KRX:048530
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW
About Intron Biotechnology, Inc.
Intron Biotechnology, Inc. is a public company listed under the ticker 048530 on the Korean market. Intron Biotechnology focuses on biotechnological innovations and solutions.
Latest news from Intron Biotechnology, Inc.
iNtRON Bio, files Two Patent Applications for IMPA™ Platform-Based Gene Editing Technology
August 26, 2025
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application
August 5, 2025
[iNtRON] Files U.S. Patent for Three Novel Endolysin-Based Drug Candidates Targeting Gram-Negative Bacteria
July 2, 2025
iNtRON Seeks a Strategic Partner to Explore the Promising Market for MRSA Decolonization
May 13, 2025
Research Intron Biotechnology, Inc.
Intron Biotechnology, Inc. company profile
View the public company page for Intron Biotechnology, Inc. on 6ix.
Intron Biotechnology, Inc. news
Read company news and market updates connected to Intron Biotechnology, Inc..
Intron Biotechnology, Inc. investor events
Find investor webinars, events, and replay context for Intron Biotechnology, Inc..